Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Transcatheter Heart Valves Pipeline Market Report Overview

Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. Transcatheter heart valves can be either balloon expandable or self-expandable.

The transcatheter heart valves pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Transcatheter Aortic Valve Replacement (TAVR)

·       Transcatheter Mitral Valve Repair (TMVR)

·       Transcatheter Mitral Valve Implantation (TMVI)

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Australia

Key Regulatory Paths ·       NMPA

·       PMA

·       CE

·       MDL

·       TGA

Leading Companies ·       3DT Holdings LLC

·       4C Medical Technologies Inc

·       Aegis Surgical Limited

·       Affluent Medical SASU

·       Anchorvalve

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Transcatheter Heart Valves Pipeline Market Segments

The key segments in the transcatheter heart valves pipeline market are transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and transcatheter mitral valve implantation (TMVI). As of November 2024, transcatheter aortic valve replacement (TAVR) accounted for the highest number of pipeline products.

Transcatheter Heart Valves Pipeline Market Analysis by Segments, 2024 (%)

Transcatheter Heart Valves Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Transcatheter Heart Valves Pipeline Market

Download a Free Report Sample

Transcatheter Heart Valves Pipeline Market Segmentation by Territories

The key territories in the transcatheter heart valve pipeline market are the US, Europe, China, Japan, and Australia, among others. As of November 2024, the US accounted for the highest number of pipeline products.

Transcatheter Heart Valves Pipeline Market Analysis by Territories, 2024 (%)

Transcatheter Heart Valves Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Transcatheter Heart Valves Pipeline Market

Download a Free Report Sample

Transcatheter Heart Valves Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the transcatheter heart valve pipeline products market are NMPA, PMA, CE, MDL, and TGA among others. As of November 2024, NMPA was the most followed pathway for pipeline products in the transcatheter heart valves market.

Transcatheter Heart Valves Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Transcatheter Heart Valves Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Transcatheter Heart Valves Pipeline Market

Download a Free Report Sample

Transcatheter Heart Valves Pipeline Market – Competitive Landscape

A few of the leading companies associated with the pacemaker pipeline market are 3DT Holdings LLC, 4C Medical Technologies Inc, Aegis Surgical Limited, Affluent Medical SASU, and Anchorvalve.

3DT Holdings LLC: 3DT Holdings LLC (3DT) is a contract research organization that offers drug development and manufacturing services. It develops, manufactures, and markets drugs for the treatment of cardiovascular, metabolic disorders, diabetes, and vascular diseases. 3DT is headquartered in Indianapolis, Indiana, the US.

4C Medical Technologies Inc: 4C Medical is a medical device company developing minimally invasive therapies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. The company’s implant is the first MR therapy with supra-annular positioning and atrial-only fixation.

Transcatheter Heart Valves Pipeline Market Analysis by Companies, 2024

Transcatheter Heart Valves Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Transcatheter Heart Valves Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Transcatheter Heart Valves Pipeline Market Segments Outlook (2024)

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Transcatheter Mitral Valve Implantation (TMVI)

Transcatheter Heart Valves Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • Australia

Transcatheter Heart Valves Pipeline Market Regulatory Paths Outlook (2024)

  • NMPA
  • PMA
  • CE
  • MDL
  • TGA

Scope

This report provides:

  • Extensive coverage of the transcatheter heart valves under development.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of transcatheter heart valves and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of transcatheter heart valves under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3DT Holdings LLC
4C Medical Technologies Inc
Aegis Surgical Limited
Affluent Medical SASU
Anchorvalve
Annulon
Anteris Technologies Ltd
Arbor Surgical Technologies, Inc.
Atlas Medical
Auris Health Inc
AVVie GmbH
Beijing Balance Medical Technology Co Ltd
Biotronik AG
Boston Children's Hospital
Boston Scientific Corp
Cardiac Dimensions Inc
CardioMech AS
Cardiovalve Ltd
Carena Healthcare Ltd
Cephea Valve Technologies, Inc.
Chengdu Silara Meditech Inc
Colibri Heart Valve LLC
ContiTech (Beijing) Medical Technology Co Ltd
coramaze technologies GmbH
CroiValve Ltd
Daidalos Solutions BV
Direct Flow Medical Inc (Inactive)
Dongguan Tiantianxiang Medical Technology Co Ltd
DSM Dyneema BV
Dura LLC
Edwards Lifesciences Corp
Emory University
Endoluminal Technology Research LLC
Endomimetics LLC
Enlight Medical Technologies (Shanghai) Co Ltd
Florida International University
Folda LLC
Foldax Inc
Georgia Institute of Technology
GrOwnValve
Half Moon Medical Inc
Hangzhou Dawneo Medical Technology Co Ltd
Hangzhou DeJin Medtech Co Ltd
Hangzhou Valgen Medtech Co Ltd
Hangzhou Valued Medtech Co Ltd
HighLife SAS
HLT, Inc.
Innovalve Bio Medical Ltd
InnovHeart SRL
JC Medical, Inc.
JenaValve Technology GmbH
Jenscare Scientific Co Ltd
Jiangsu Zhenyi Medical Technology Co Ltd
Jinshi Biotechnology (Changshu) Co Ltd
Juxin Medical Technology (Shenzhen) Co Ltd
Kekai Life Sciences
KOKA Lifesciences Co Ltd
Laguna Tech USA Inc
LaPlace Interventional Inc
Lepu Medical Technology (Beijing) Co Ltd
LivaNova PLC
Mayo Clinic
Medfree Inc
Medtronic Plc
Meril Life Sciences Pvt Ltd
Micro Interventional Devices, Inc.
MicroPort CardioFlow Medtech Corp
MicroPort Scientific Corp
Mitral Heal
Mitralix Ltd.
MitrAssist Ltd.
Mitria Medical LLC
MValve Technologies Ltd.
Nanjing Saint Medical Technology Co Ltd
NaviGate Cardiac Structures, Inc.
Neochord Inc
Neoolife Inc
Neovasc Inc
Ningbo Jianshi Biotechnology Co Ltd
North Carolina State University
Novogate Medical Ltd.
NVT GmbH
Nyra Medical Inc
Open Stent Solution
OrbusNeich P&F
P+F Products + Features GmbH
Peca Labs Inc
Peijia Medical Ltd
Pipeline Medical Technologies Inc
Polares Medical SA
PolyNova Cardiovascular Inc
Polyvascular Inc
RegenaGraft
ReValve Med Inc
RUA Life Sciences Plc
SAS Cormove
Shanghai Hanyu Medical Technology Co Ltd
Shanghai Healing Medical Instruments Co Ltd
Shanghai Huihe Medical Technology Co Ltd
Shanghai Lixiao Medical Technology Co Ltd
Shanghai NewMed Medical Technology Co Ltd
Shanghai Push Medical Equipment Co Ltd
Shanghai Shenqi Medical Technology Co Ltd
Shockwave Medical Inc
Sino Medical Sciences Technology Inc
St. Jude Medical LLC
StarTric Srl
Stony Brook University
Strait Access Technologies (Pty) Ltd
Sutra Medical Inc
Suzhou Jiecheng Medical Technology Co Ltd
Symetis SA
The University of British Columbia
Thubrikar Aortic Valve, Inc.
Tioga Medical Inc
Trinity College Dublin
Trisol Medical Ltd
University College London
University of California
University of California San Francisco
University of Cambridge
University of Iowa
University of Pennsylvania
Valcare Medical
VALFIX Medical Ltd
Valtech Cardio Ltd
Valve Medical Ltd.
Vascudyne Inc
Vascular Concepts Ltd
Vdyne LLC
Venus Medtech Hangzhou Inc
Venus MedTech of America
Versa Vascular Inc
Vesalius Cardiovascular Inc
Vvital Biomed Ltd
Xeltis AG
Youngheartvalve LLC

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Transcatheter Heart Valves Overview

3 Products under Development

3.1 Transcatheter Heart Valves – Pipeline Products by Stage of Development

3.2 Transcatheter Heart Valves – Pipeline Products by Segment

3.3 Transcatheter Heart Valves – Pipeline Products by Territory

3.4 Transcatheter Heart Valves – Pipeline Products by Regulatory Path

3.5 Transcatheter Heart Valves – Pipeline Products by Estimated Approval Date

3.6 Transcatheter Heart Valves – Ongoing Clinical Trials

4 Transcatheter Heart Valves – Pipeline Products under Development by Companies

4.1 Transcatheter Heart Valves Companies – Pipeline Products by Stage of Development

4.2 Transcatheter Heart Valves – Pipeline Products by Stage of Development

5 Transcatheter Heart Valves Companies and Product Overview

5.1 3DT Holdings LLC Company Overview

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview

5.2 4C Medical Technologies Inc Company Overview

5.2.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Aegis Surgical Limited Company Overview

5.3.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview

5.4 Affluent Medical SASU Company Overview

5.4.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

5.5 Anchorvalve Company Overview

5.5.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview

5.6 Annulon Company Overview

5.6.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview

5.7 Anteris Technologies Ltd Company Overview

5.7.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.8 Arbor Surgical Technologies, Inc. Company Overview

5.8.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.9 Atlas Medical Company Overview

5.9.1 Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview

5.10 Auris Health Inc Company Overview

5.10.1 Auris Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 AVVie GmbH Company Overview

5.11.1 AVVie GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.12 Beijing Balance Medical Technology Co Ltd Company Overview

5.12.1 Beijing Balance Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.13 Biotronik AG Company Overview

5.13.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview

5.14 Boston Children’s Hospital Company Overview

5.14.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.15 Boston Scientific Corp Company Overview

5.15.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.16 Cardiac Dimensions Inc Company Overview

5.16.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 CardioMech AS Company Overview

5.17.1 CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview

5.18 Cardiovalve Ltd Company Overview

5.18.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.19 Carena Healthcare Ltd Company Overview

5.19.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 Cephea Valve Technologies, Inc. Company Overview

5.20.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.21 Chengdu Silara Meditech Inc Company Overview

5.21.1 Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Colibri Heart Valve LLC Company Overview

5.22.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview

5.23 ContiTech (Beijing) Medical Technology Co Ltd Company Overview

5.23.1 ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.24 coramaze technologies GmbH Company Overview

5.24.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.25 CroiValve Ltd Company Overview

5.25.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.26 Daidalos Solutions BV Company Overview

5.26.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview

5.27 Direct Flow Medical Inc (Inactive) Company Overview

5.27.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.28 Dongguan Tiantianxiang Medical Technology Co Ltd Company Overview

5.28.1 Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.29 DSM Dyneema BV Company Overview

5.29.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview

5.30 Dura LLC Company Overview

5.30.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview

5.31 Edwards Lifesciences Corp Company Overview

5.31.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview

5.32 Emory University Company Overview

5.32.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview

5.33 Endoluminal Technology Research LLC Company Overview

5.33.1 Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview

5.34 Endomimetics LLC Company Overview

5.34.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.35 Enlight Medical Technologies (Shanghai) Co Ltd Company Overview

5.35.1 Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.36 Florida International University Company Overview

5.36.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview

5.37 Folda LLC Company Overview

5.37.1 Folda LLC Pipeline Products & Ongoing Clinical Trials Overview

5.38 Foldax Inc Company Overview

5.38.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview

5.39 Georgia Institute of Technology Company Overview

5.39.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.40 GrOwnValve Company Overview

5.40.1 GrOwnValve Pipeline Products & Ongoing Clinical Trials Overview

5.41 Half Moon Medical Inc Company Overview

5.41.1 Half Moon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.42 Hangzhou Dawneo Medical Technology Co Ltd Company Overview

5.42.1 Hangzhou Dawneo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Hangzhou DeJin Medtech Co Ltd Company Overview

5.43.1 Hangzhou DeJin Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.44 Hangzhou Valgen Medtech Co Ltd Company Overview

5.44.1 Hangzhou Valgen Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.45 Hangzhou Valued Medtech Co Ltd Company Overview

5.45.1 Hangzhou Valued Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.46 HighLife SAS Company Overview

5.46.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview

5.47 HLT, Inc. Company Overview

5.47.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.48 Innovalve Bio Medical Ltd Company Overview

5.48.1 Innovalve Bio Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.49 InnovHeart SRL Company Overview

5.49.1 InnovHeart SRL Pipeline Products & Ongoing Clinical Trials Overview

5.50 JC Medical, Inc. Company Overview

5.50.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.51 JenaValve Technology GmbH Company Overview

5.51.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.52 Jenscare Scientific Co Ltd Company Overview

5.52.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.53 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview

5.53.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.54 Jinshi Biotechnology (Changshu) Co Ltd Company Overview

5.54.1 Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.55 Juxin Medical Technology (Shenzhen) Co Ltd Company Overview

5.55.1 Juxin Medical Technology (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.56 Kekai Life Sciences Company Overview

5.56.1 Kekai Life Sciences Pipeline Products & Ongoing Clinical Trials Overview

5.57 KOKA Lifesciences Co Ltd Company Overview

5.57.1 KOKA Lifesciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.58 Laguna Tech USA Inc Company Overview

5.58.1 Laguna Tech USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.59 LaPlace Interventional Inc Company Overview

5.59.1 LaPlace Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 Lepu Medical Technology (Beijing) Co Ltd Company Overview

5.60.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.61 LivaNova PLC Company Overview

5.61.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview

5.62 Mayo Clinic Company Overview

5.62.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

5.63 Medfree Inc Company Overview

5.63.1 Medfree Inc Pipeline Products & Ongoing Clinical Trials Overview

5.64 Medtronic Plc Company Overview

5.64.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.65 Meril Life Sciences Pvt Ltd Company Overview

5.65.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.66 Micro Interventional Devices, Inc. Company Overview

5.66.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.67 MicroPort CardioFlow Medtech Corp Company Overview

5.67.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview

5.68 MicroPort Scientific Corp Company Overview

5.68.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.69 Mitral Heal Company Overview

5.69.1 Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview

5.70 Mitralix Ltd. Company Overview

5.70.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.71 MitrAssist Ltd. Company Overview

5.71.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.72 Mitria Medical LLC Company Overview

5.72.1 Mitria Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.73 MValve Technologies Ltd. Company Overview

5.73.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.74 Nanjing Saint Medical Technology Co Ltd Company Overview

5.74.1 Nanjing Saint Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.75 NaviGate Cardiac Structures, Inc. Company Overview

5.75.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.76 Neochord Inc Company Overview

5.76.1 Neochord Inc Pipeline Products & Ongoing Clinical Trials Overview

5.77 Neoolife Inc Company Overview

5.77.1 Neoolife Inc Pipeline Products & Ongoing Clinical Trials Overview

5.78 Neovasc Inc Company Overview

5.78.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview

5.79 Ningbo Jianshi Biotechnology Co Ltd Company Overview

5.79.1 Ningbo Jianshi Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.80 North Carolina State University Company Overview

5.80.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

5.81 Novogate Medical Ltd. Company Overview

5.81.1 Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.82 NVT GmbH Company Overview

5.82.1 NVT GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.83 Nyra Medical Inc Company Overview

5.83.1 Nyra Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.84 Open Stent Solution Company Overview

5.84.1 Open Stent Solution Pipeline Products & Ongoing Clinical Trials Overview

5.85 OrbusNeich P&F Company Overview

5.85.1 OrbusNeich P&F Pipeline Products & Ongoing Clinical Trials Overview

5.86 P+F Products + Features GmbH Company Overview

5.86.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.87 Peca Labs Inc Company Overview

5.87.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

5.88 Peijia Medical Ltd Company Overview

5.88.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.89 Pipeline Medical Technologies Inc Company Overview

5.89.1 Pipeline Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.90 Polares Medical SA Company Overview

5.90.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview

5.91 PolyNova Cardiovascular Inc Company Overview

5.91.1 PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.92 Polyvascular Inc Company Overview

5.92.1 Polyvascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.93 RegenaGraft Company Overview

5.93.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview

5.94 ReValve Med Inc Company Overview

5.94.1 ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview

5.95 RUA Life Sciences Plc Company Overview

5.95.1 RUA Life Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview

5.96 SAS Cormove Company Overview

5.96.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview

5.97 Shanghai Hanyu Medical Technology Co Ltd Company Overview

5.97.1 Shanghai Hanyu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.98 Shanghai Healing Medical Instruments Co Ltd Company Overview

5.98.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.99 Shanghai Huihe Medical Technology Co Ltd Company Overview

5.99.1 Shanghai Huihe Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.100 Shanghai Lixiao Medical Technology Co Ltd Company Overview

5.100.1 Shanghai Lixiao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.101 Shanghai NewMed Medical Technology Co Ltd Company Overview

5.101.1 Shanghai NewMed Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.102 Shanghai Push Medical Equipment Co Ltd Company Overview

5.102.1 Shanghai Push Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.103 Shanghai Shenqi Medical Technology Co Ltd Company Overview

5.103.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.104 Shockwave Medical Inc Company Overview

5.104.1 Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.105 Sino Medical Sciences Technology Inc Company Overview

5.105.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.106 St. Jude Medical LLC Company Overview

5.106.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.107 StarTric Srl Company Overview

5.107.1 StarTric Srl Pipeline Products & Ongoing Clinical Trials Overview

5.108 Stony Brook University Company Overview

5.108.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview

5.109 Strait Access Technologies (Pty) Ltd Company Overview

5.109.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.110 Sutra Medical Inc Company Overview

5.110.1 Sutra Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.111 Suzhou Jiecheng Medical Technology Co Ltd Company Overview

5.111.1 Suzhou Jiecheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.112 Symetis SA Company Overview

5.112.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview

5.113 The University of British Columbia Company Overview

5.113.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview

5.114 Thubrikar Aortic Valve, Inc. Company Overview

5.114.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.115 Tioga Medical Inc Company Overview

5.115.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.116 Trinity College Dublin Company Overview

5.116.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview

5.117 Trisol Medical Ltd Company Overview

5.117.1 Trisol Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.118 University College London Company Overview

5.118.1 University College London Pipeline Products & Ongoing Clinical Trials Overview

5.119 University of California Company Overview

5.119.1 University of California Pipeline Products & Ongoing Clinical Trials Overview

5.120 University of California San Francisco Company Overview

5.120.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview

5.121 University of Cambridge Company Overview

5.121.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview

5.122 University of Iowa Company Overview

5.122.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview

5.123 University of Pennsylvania Company Overview

5.123.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview

5.124 Valcare Medical Company Overview

5.124.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview

5.125 VALFIX Medical Ltd Company Overview

5.125.1 VALFIX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.126 Valtech Cardio Ltd Company Overview

5.126.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.127 Valve Medical Ltd. Company Overview

5.127.1 Valve Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.128 Vascudyne Inc Company Overview

5.128.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview

5.129 Vascular Concepts Ltd Company Overview

5.129.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.130 Vdyne LLC Company Overview

5.130.1 Vdyne LLC Pipeline Products & Ongoing Clinical Trials Overview

5.131 Venus Medtech Hangzhou Inc Company Overview

5.131.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

5.132 Venus MedTech of America Company Overview

5.132.1 Venus MedTech of America Pipeline Products & Ongoing Clinical Trials Overview

5.133 Versa Vascular Inc Company Overview

5.133.1 Versa Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.134 Vesalius Cardiovascular Inc Company Overview

5.134.1 Vesalius Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.135 Vvital Biomed Ltd Company Overview

5.135.1 Vvital Biomed Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.136 Xeltis AG Company Overview

5.136.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview

5.137 Youngheartvalve LLC Company Overview

5.137.1 Youngheartvalve LLC Pipeline Products & Ongoing Clinical Trials Overview

6 Transcatheter Heart Valves- Recent Developments

6.1 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024

6.2 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

6.3 Sep 24, 2024: New Tricuspid Valve Procedure Helps Patients Avoid Open-Heart Surgery

6.4 Aug 31, 2024: Transcatheter Edge-To-Edge Repair Is Non-inferior to Surgery in Patients with Secondary Mitral Regurgitation

6.5 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.6 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.7 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.8 Aug 09, 2024: No Evidence to Support the Variation in Price the NHS Is Paying for Valves Used in Keyhole Heart Procedures

6.9 Jul 18, 2024: Hanyang University Medical Center quests for zero in-hospital mortality in TAVI procedures

6.10 Jul 11, 2024: A New Era in Heart Surgery – Israeli Biomed Company TruLeaf Medical’s Two Needle Sticks Procedure for Mitral Valve Replacement

6.11 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.12 Jun 06, 2024: MiRus Siegel TAVR: First in Human Results Presented at New York Valves

6.13 Apr 18, 2024: Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement

6.14 Apr 07, 2024: Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It

6.15 Apr 05, 2024: RUA Life Sciences : Business Update

6.16 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.17 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.18 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference

6.19 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.20 Feb 13, 2024: Interventional Cardiology at Adventist Health Glendale Reaches Milestone with 500th TAVR Procedure

6.21 Feb 09, 2024: Emory performs 5,000th TAVR cardiac procedure

6.22 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.23 Jan 04, 2024: EISENHOWER HEALTH BECOMES FIRST EDWARDS BENCHMARK PROGRAM OBSERVATION SITE FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BEGINS HOSTING TAVR TEAMS FROM ACROSS THE NATION

6.24 Nov 30, 2023: RUA Life Sciences Plans USD4.8 Million Total Equity Raise

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Transcatheter Heart Valves – Pipeline Products by Stage of Development

Transcatheter Heart Valves – Pipeline Products by Segment

Transcatheter Heart Valves – Pipeline Products by Territory

Transcatheter Heart Valves – Pipeline Products by Regulatory Path

Transcatheter Heart Valves – Pipeline Products by Estimated Approval Date

Transcatheter Heart Valves – Ongoing Clinical Trials

Transcatheter Heart Valves Companies – Pipeline Products by Stage of Development

Transcatheter Heart Valves – Pipeline Products by Stage of Development

3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview

Tissue Heart Valve – Product Status

Tissue Heart Valve – Product Description

4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

AltaValve – Product Status

AltaValve – Product Description

AltaValve Transcatheter Mitral Valve Replacement Device – Product Status

AltaValve Transcatheter Mitral Valve Replacement Device – Product Description

4C Medical Technologies Inc – Ongoing Clinical Trials Overview

AltaValve Transcatheter Mitral Valve Replacement Device – AltaValve Early Feasibility Study Protocol

AltaValve Transcatheter Mitral Valve Replacement Device – AltaValve Pivotal Trial

Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview

pTAo-TAVR – Product Status

pTAo-TAVR – Product Description

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview

Epygon – Product Status

Epygon – Product Description

Affluent Medical SASU – Ongoing Clinical Trials Overview

Epygon – First-in-human Clinical Study for Treatment of Severe Mitral Valve Insufficiency with Epygon Transcatheter Mitral Valve System (MINERVA FIH)

Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview

Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) – Product Status

Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) – Product Description

Sutureless Trans-Catheter Tricuspid Valve Replacement (TTVR) – Product Status

Sutureless Trans-Catheter Tricuspid Valve Replacement (TTVR) – Product Description

Annulon Pipeline Products & Ongoing Clinical Trials Overview

Mitral Valve Replacement Device – Product Status

Mitral Valve Replacement Device – Product Description

Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

DurAVR THV System – Product Status

DurAVR THV System – Product Description

VClip – Product Status

VClip – Product Description

Anteris Technologies Ltd – Ongoing Clinical Trials Overview

DurAVR THV System – A Pivotal Study to Evaluate the Efficacy of DurAVR THV System for the Treatment Aortic Stenosis

DurAVR THV System – DurAVR THV System in a Valve-in-Valve Procedure: A First Successful Implantation in Humans

DurAVR THV System – DurAVR THV System: European Early Feasibility Study

DurAVR THV System – Use of DurAVR THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

DurAVR THV System – Use of DurAVR THV System in Subjects with Severe Aortic Stenosis: First In Human Study

Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Trilogy Aortic Valve System – Product Status

Trilogy Aortic Valve System – Product Description

Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview

Endurance Valve – Product Status

Endurance Valve – Product Description

Auris Health Inc Pipeline Products & Ongoing Clinical Trials Overview

AorTx Valve – Product Status

AorTx Valve – Product Description

AVVie GmbH Pipeline Products & Ongoing Clinical Trials Overview

Mitral Butterfly – Product Status

Mitral Butterfly – Product Description

Beijing Balance Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Renatus – Product Status

Renatus – Product Description

Transcatheter Valve-In-Valve System – Product Status

Transcatheter Valve-In-Valve System – Product Description

Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview

BIOVALVE Resheathable Transcatheter Aortic Valve – Product Status

BIOVALVE Resheathable Transcatheter Aortic Valve – Product Description

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

Pulmonary Valve Replacement Device – Product Status

Pulmonary Valve Replacement Device – Product Description

Two Piece Replacement Heart Valve – Product Status

Two Piece Replacement Heart Valve – Product Description

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

ACURATE neo2 Aortic Valve System – Product Status

ACURATE neo2 Aortic Valve System – Product Description

Gen 4 Lotus Valve System – Product Status

Gen 4 Lotus Valve System – Product Description

Lotus Edge Sheath 15F – Product Status

Lotus Edge Sheath 15F – Product Description

Lotus Edge Valve System – 21mm – Product Status

Lotus Edge Valve System – 21mm – Product Description

Lotus Edge Valve System – 29mm – Product Status

Lotus Edge Valve System – 29mm – Product Description

LOTUS Mantra – Product Status

LOTUS Mantra – Product Description

NG ACURATE – Product Status

NG ACURATE – Product Description

Boston Scientific Corp – Ongoing Clinical Trials Overview

ACURATE neo2 Aortic Valve System – ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects Indicated for TAVR

ACURATE neo2 Aortic Valve System – Project to Look for Early Discharge in Patients Undergoing TAVI With ACURATE – An International Multi-center Early Discharge TAVI Program

ACURATE neo2 Aortic Valve System – Prospective Evaluation Complementing Investigation with Acurate Neo Device

ACURATE neo2 Aortic Valve System – Prospective, Randomized, Cost-utility Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Brazil

ACURATE neo2 Aortic Valve System – PROVE ACURATE neo2 – Post Market Safety and Performance Surveillance in Aortic Stenosis

ACURATE neo2 Aortic Valve System – Randomized Study Comparing Both Latest Generation Self-expanding Valves and Local Anesthesia Vs. Conscious Sedation in Transcatheter Aortic Valve Implantation

ACURATE neo2 Aortic Valve System – The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview

CARILLON Mitral Contour System – Product Status

CARILLON Mitral Contour System – Product Description

Cardiac Dimensions Inc – Ongoing Clinical Trials Overview

CARILLON Mitral Contour System – Assessment of the Carillon Mitral Contour System in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation

CARILLON Mitral Contour System – European Registry of Transcatheter Repair for Secondary Mitral Regurgitation

CARILLON Mitral Contour System – The CINCH-FMR Post-Market Registry: Percutaneous Repair in Functional Mitral Regurgitation

CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview

Artificial Chord – Product Status

Artificial Chord – Product Description

CardioMech AS – Ongoing Clinical Trials Overview

Artificial Chord – Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)

Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cardiovalve Transcatheter Tricuspid Valve System – Product Status

Cardiovalve Transcatheter Tricuspid Valve System – Product Description

Cardiovalve Transfemoral Mitral Valve System – Product Status

Cardiovalve Transfemoral Mitral Valve System – Product Description

Cardiovalve Ltd – Ongoing Clinical Trials Overview

Cardiovalve Transfemoral Mitral Valve System – Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation

Cardiovalve Transfemoral Mitral Valve System – European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study

Cardiovalve Transfemoral Mitral Valve System – Evaluation of a Transcatheter Mitral Valve Replacement System for the Treatment of Severe Mitral Regurgitation with High Surgical Risk: A Chinese Feasibility Study

Cardiovalve Transcatheter Tricuspid Valve System – Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation

Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview

Pillar 3D Printed Replacement Heart Valve – Product Status

Pillar 3D Printed Replacement Heart Valve – Product Description

Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Cephea Transcatheter Mitral Valve Replacement System – Product Status

Cephea Transcatheter Mitral Valve Replacement System – Product Description

Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview

Transcatheter Aortic Valve System – Product Status

Transcatheter Aortic Valve System – Product Description

Chengdu Silara Meditech Inc – Ongoing Clinical Trials Overview

Transcatheter Aortic Valve System – A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System in Patients with Severe Aortic Stenosis with or without Moderate or Lower Degree Regurgitation

Transcatheter Aortic Valve System – A Prospective, Multicenter, Single-arm Target-value Clinical Trial To Evaluate the Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis

Transcatheter Aortic Valve System – To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Symptomatic Aortic Insufficiency

Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview

Colibri TAVI System – Product Status

Colibri TAVI System – Product Description

Delta Aortic Heart Valve – Product Status

Delta Aortic Heart Valve – Product Description

Mitral Valve – Product Status

Mitral Valve – Product Description

Second-Generation TAVI System – Product Status

Second-Generation TAVI System – Product Description

Venibri Transcatheter Heart Valve System – Product Status

Venibri Transcatheter Heart Valve System – Product Description

Colibri Heart Valve LLC – Ongoing Clinical Trials Overview

Colibri TAVI System – A Prospective, Single Arm Clinical Investigation Evaluating Safety and Performance of the Colibri Transcatheter Aortic Heart Valve System for the Treatment of Symptomatic Severe Aortic Stenosis Via Transfemoral Access in High Surgical Risk Patients

ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Balloon-Expandable Transcatheter Aortic Valve Replacement Device – Product Status

Balloon-Expandable Transcatheter Aortic Valve Replacement Device – Product Description

coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview

Mitramaze Valve Repair System – Product Status

Mitramaze Valve Repair System – Product Description

CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview

Duo Tricuspid Coaptation Valve – Product Status

Duo Tricuspid Coaptation Valve – Product Description

CroiValve Ltd – Ongoing Clinical Trials Overview

Duo Tricuspid Coaptation Valve – A European Feasibility Study of the CroiValve DUO Transcatheter Tricuspid Coaptation Valve System in Patients with Tricuspid Regurgitation

Duo Tricuspid Coaptation Valve – Early Feasibility Study of the DUO Transcatheter Tricuspid Coaptation Valve System in Patients with Tricuspid Regurgitation

Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview

Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) – Product Status

Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) – Product Description

Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

18F Direct Flow Medical Transcatheter Aortic Valve System – Product Status

18F Direct Flow Medical Transcatheter Aortic Valve System – Product Description

22F Percutaneous Aortic Valve System – Product Status

22F Percutaneous Aortic Valve System – Product Description

Direct Flow Medical Transcatheter Mitral Valve – Product Status

Direct Flow Medical Transcatheter Mitral Valve – Product Description

Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

TAVR – Cardiovascular – Product Status

TAVR – Cardiovascular – Product Description

DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview

Dyneema Purity – Transcatheter Heart Valve – Product Status

Dyneema Purity – Transcatheter Heart Valve – Product Description

Dura LLC Pipeline Products & Ongoing Clinical Trials Overview

Joyce Fit TPVR System – Product Status

Joyce Fit TPVR System – Product Description

LowPro Valve – Product Status

LowPro Valve – Product Description

Sutra TMVR System – Product Status

Sutra TMVR System – Product Description

Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview

CardiAQ Mitral Valve – Product Status

CardiAQ Mitral Valve – Product Description

Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System – Product Status

Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System – Product Description

EVOQUE Mitral Eos Valve Replacement Device – Product Status

EVOQUE Mitral Eos Valve Replacement Device – Product Description

FORMA Tricuspid Repair System – Product Status

FORMA Tricuspid Repair System – Product Description

FORTIS Mitral Transcatheter Heart Valve – Product Status

FORTIS Mitral Transcatheter Heart Valve – Product Description

Monarc Transcatheter Mitral Repair System – Product Status

Monarc Transcatheter Mitral Repair System – Product Description

Next Gen CENTERA – Product Status

Next Gen CENTERA – Product Description

PASCAL Ace Transcatheter Tricuspid Valve Repair System – Product Status

PASCAL Ace Transcatheter Tricuspid Valve Repair System – Product Description

PASCAL Precision Transcatheter Tricuspid Valve Repair System – Product Status

PASCAL Precision Transcatheter Tricuspid Valve Repair System – Product Description

PASCAL STABILX – Product Status

PASCAL STABILX – Product Description

PASCAL Transcatheter Mitral Valve Repair System – FMR – Product Status

PASCAL Transcatheter Mitral Valve Repair System – FMR – Product Description

SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Product Status

SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Product Description

SAPIEN 3 THV – Moderate Aortic Stenosis – Product Status

SAPIEN 3 THV – Moderate Aortic Stenosis – Product Description

Sapien 3 Ultra Evolutionary Transcatheter Heart Valve – Product Status

Sapien 3 Ultra Evolutionary Transcatheter Heart Valve – Product Description

SAPIEN M3 – Product Status

SAPIEN M3 – Product Description

SAPIEN X4 – Product Status

SAPIEN X4 – Product Description

Edwards Lifesciences Corp – Ongoing Clinical Trials Overview

FORTIS Mitral Transcatheter Heart Valve – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation

CardiAQ Mitral Valve – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation

FORMA Tricuspid Repair System – International Multisite Transcatheter Tricuspid Valve Therapies Registry

SAPIEN M3 – SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access

SAPIEN 3 THV – Moderate Aortic Stenosis – Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD)

EVOQUE Mitral Eos Valve Replacement Device – Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation

SAPIEN 3 THV – Asymptomatic Severe Aortic Stenosis – Risk of Coronary Obstruction Due to Sinus Sequestration by Redo Transcatheter Aortic Valve Implantation in Japanese Patients with SAPIEN 3

SAPIEN X4 – Prospective, Single Arm, Multicentre, Feasibility Study to Demonstrate the Safety and Functionality of the Edwards 12f Sheath Introducer Set In Conjunction with the Sapien X4 Transcatheter Heart Valve (THV) In Subjects with Symptomatic, Severe, Calcific Aortic Stenosis (AS) (Protocol Number: 2023-06)

SAPIEN X4 – Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve

SAPIEN X4 – Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve – Mitral

PASCAL Transcatheter Mitral Valve Repair System – FMR – Catheter Ablation or Percutaneous Mitral Valve Repair to Treat Essential (Moderate/Severe) Functional Mitral Regurgitation in Patients with Atrial Fibrillation – a Pilot Trial

PASCAL Transcatheter Mitral Valve Repair System – FMR – Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients with Mitral Regurgitation

PASCAL Transcatheter Mitral Valve Repair System – FMR – Transcatheter Repair of Mitral Regurgitation with Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-up (PMCF)

Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System – Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System: Investigation of Safety and Clinical Efficacy Using a Novel Device in Patients with at Least Severe Tricuspid Regurgitation in JAPAN

Emory University Pipeline Products & Ongoing Clinical Trials Overview

MitraCath – Product Status

MitraCath – Product Description

MitraPlug – Product Status

MitraPlug – Product Description

Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview

Balloon Expandable Paniagua Heart Valve – Product Status

Balloon Expandable Paniagua Heart Valve – Product Description

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Transcatheter Heart Valve – Product Status

Transcatheter Heart Valve – Product Description

Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

NovoClasp Transfemoral Mitral Valve Repair System – Product Status

NovoClasp Transfemoral Mitral Valve Repair System – Product Description

Second-Generation Mitral Valve Repair System – Product Status

Second-Generation Mitral Valve Repair System – Product Description

Enlight Medical Technologies (Shanghai) Co Ltd – Ongoing Clinical Trials Overview

NovoClasp Transfemoral Mitral Valve Repair System – A Prospective, Multicenter, Single-arm Clinical Study of NovoClasp Transcatheter Mitral Valve Clip and Steerable Guide Catheter for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation (DMR)

Florida International University Pipeline Products & Ongoing Clinical Trials Overview

Percutaneous Aortic Heart Valve – Product Status

Percutaneous Aortic Heart Valve – Product Description

Folda LLC Pipeline Products & Ongoing Clinical Trials Overview

Foldavalve – Product Status

Foldavalve – Product Description

Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview

Tria Transcatheter Aortic Valve Replacement Device – Product Status

Tria Transcatheter Aortic Valve Replacement Device – Product Description

Tria Transcatheter Mitral Valve Replacement Device – Product Status

Tria Transcatheter Mitral Valve Replacement Device – Product Description

Tria Transcatheter Tricuspid Valve Replacement Device – Product Status

Tria Transcatheter Tricuspid Valve Replacement Device – Product Description

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Transcatheter Heart Valve – Product Status

Transcatheter Heart Valve – Product Description

GrOwnValve Pipeline Products & Ongoing Clinical Trials Overview

ChildValve – Product Status

ChildValve – Product Description

GrOwnValve – Ongoing Clinical Trials Overview

ChildValve – A First-in-Human Feasibility Study to Evaluate the Safety (and Short Term Effectiveness) of the Autologous GrOwnValve Transcatheter Pulmonary Heart Valve [GECT]

Half Moon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Half Moon TMVr System – Product Status

Half Moon TMVr System – Product Description

Half Moon Medical Inc – Ongoing Clinical Trials Overview

Half Moon TMVr System – Evaluation of the Safety and Performance of the Half Moon Transcatheter Mitral Valve Repair System in High Risk Patients with Severe, Symptomatic Mitral Regurgitation

Hangzhou Dawneo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

NeoNova Transcatheter Mitral Valve Edge-to-Edge Repair System – Product Status

NeoNova Transcatheter Mitral Valve Edge-to-Edge Repair System – Product Description

Hangzhou Dawneo Medical Technology Co Ltd – Ongoing Clinical Trials Overview

NeoNova Transcatheter Mitral Valve Edge-to-Edge Repair System – Dawneo Neonova Transcatheter Mitral Valve Edge-to Edge Repair System Pivotal Clinical Trial (Nomr): A Prospective, Multicenter, Randomized, Objective Performance Criteria Trial to Evaluate the Safety and Effectiveness of Transcatheter Valve Edge-to-edge Repair System in Patients with Moderate-to-severe and Severe Degenerate Mitral Regurgitation

Hangzhou DeJin Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

MitralStitch – Product Status

MitralStitch – Product Description

Hangzhou Valgen Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Dragonfly Transcatheter Mitral Valve Clamping System – Product Status

Dragonfly Transcatheter Mitral Valve Clamping System – Product Description

DragonRing Transcatheter Valvuloplasty System – Product Status

DragonRing Transcatheter Valvuloplasty System – Product Description

Hangzhou Valgen Medtech Co Ltd – Ongoing Clinical Trials Overview

Dragonfly Transcatheter Mitral Valve Clamping System – Safety and Performance Evaluation Study of DragonFly System for Mitral Regurgitation

DragonRing Transcatheter Valvuloplasty System – Clinical Study of Transcatheter Valvuloplasty Ring System in the Treatment of Moderate to Severe Functional Mitral Regurgitation

Hangzhou Valued Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

DragonFly – Product Status

DragonFly – Product Description

Hangzhou Valued Medtech Co Ltd – Ongoing Clinical Trials Overview

DragonFly – A Clinical Study of Management of Severe Tricuspid Regurgitation with Transcatheter Mitral Valve Clamping System

DragonFly – A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Safety and Effectiveness of Dragonfly Transcatheter Mitral Valve Repair System for the Treatment of Degenerative Mitral Regurgitation (DMR) Subjects

DragonFly – A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Safety and Effectiveness of Dragonfly Transcatheter Mitral Valve Repair System for the Treatment of Functional Mitral Regurgitation (FMR) Subjects

DragonFly – Dragonfly-M Transcatheter Mitral Valve Repair System Early Feasibility Study

HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview

HighLife Trans-Septal Mitral Valve Replacement – Product Status

HighLife Trans-Septal Mitral Valve Replacement – Product Description

HighLife SAS – Ongoing Clinical Trials Overview

HighLife Trans-Septal Mitral Valve Replacement – A Pivotal Study Evaluate the Safety and Effectiveness of the HighLife TSMVR Solution in Subjects with Moderate to Severe Functional Mitral Regurgitation

HighLife Trans-Septal Mitral Valve Replacement – A Prospective, Multicentric Clinical Trial Protocol to Evaluate the Safety and Efficacy of the HighLife Trans-Septal Transcatheter Mitral Valve Replacement System for the Treatment of Moderate-severe or Severe Mitral Regurgitation With Single-arm Objective Performance Criteria

HighLife Trans-Septal Mitral Valve Replacement – A Study of Large Annulus Valve (LAV) Implantation in Patients with Mitral Regurgitation (MR)

HighLife Trans-Septal Mitral Valve Replacement – An Early Feasibility Study of the HighLife 28mm Trans-septal Transcatheter Mitral Valve Replacement System

HighLife Trans-Septal Mitral Valve Replacement – Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

HighLife Trans-Septal Mitral Valve Replacement – Feasibility Study on the Safety and Effectiveness of Highlife Transcatheter Mitral Valve Replacement System in Chinese Patients Who Need Mitral Valve Surgical Intervention but Are Not Suitable for Routine Surgical Intervention

HighLife Trans-Septal Mitral Valve Replacement – HighLife TSMVR Feasibility Study of the Open Cell CLARITY Valve in Patients with Moderate-severe or Severe MR, High Surgical Risk and with a High Risk for Left Ventricular Outflow Tract Obstruction (LVOTO)

HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Meridian II Transcatheter Aortic Valve Replacement System – Product Status

Meridian II Transcatheter Aortic Valve Replacement System – Product Description

Innovalve Bio Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

TMVR Innostay System – Product Status

TMVR Innostay System – Product Description

Innovalve Bio Medical Ltd – Ongoing Clinical Trials Overview

TMVR Innostay System – TVMR with the Innovalve System Trial – Early Feasibility Study

TMVR Innostay System – TVMR With the Innovalve System Trial – First In Human Israel

TMVR Innostay System – TVMR With the Innovalve System Trial – Pilot in Georgia

TMVR Innostay System – TVMR with the Innovalve System Trial – Pilot Study in Italy

InnovHeart SRL Pipeline Products & Ongoing Clinical Trials Overview

Saturn TMVR Prosthesis – Transapical – Product Status

Saturn TMVR Prosthesis – Transapical – Product Description

Saturn TMVR Prosthesis – Transeptal – Product Status

Saturn TMVR Prosthesis – Transeptal – Product Description

Saturn TMVR Prosthesis – Transfemoral – Product Status

Saturn TMVR Prosthesis – Transfemoral – Product Description

InnovHeart SRL – Ongoing Clinical Trials Overview

Saturn TMVR Prosthesis – Transapical – SATURN Transcatheter Mitral Valve Replacement for Functional Mitral Regurgitation

Saturn TMVR Prosthesis – Transeptal – Reduction or Elimination of Mitral Regurgitation With the SATURN Trans-Septal TMVR System in Patients With Severe Symptomatic Mitral Regurgitation – CASSINI-EU Trial

JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

J-Valve TAVI System – Transapical – Product Status

J-Valve TAVI System – Transapical – Product Description

J-Valve TF System – Product Status

J-Valve TF System – Product Description

JC Medical, Inc. – Ongoing Clinical Trials Overview

J-Valve TF System – J-Valve Compassionate Use Cases

J-Valve TF System – J-Valve TF Early Feasibility Study

J-Valve TF System – J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy

JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview

JenaValve Pericardial TAVR System – Product Status

JenaValve Pericardial TAVR System – Product Description

Trilogy Heart Valve System – Product Status

Trilogy Heart Valve System – Product Description

JenaValve Technology GmbH – Ongoing Clinical Trials Overview

JenaValve Pericardial TAVR System – A Study to Assess Safety and Effectiveness of the JenaValve Trilogy Heart Valve System in the Treatment of High Surgical Risk Patients with Symptomatic, Severe Aortic Regurgitation (AR)

JenaValve Pericardial TAVR System – THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation (AR)

Trilogy Heart Valve System – A Prospective, Multicenter, Single-group Clinical Study to Evaluate the Safety and Efficacy of Peijia Medical Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Regurgitation

Trilogy Heart Valve System – A Study to Assess Safety and Effectiveness of the JenaValve Trilogy Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients with Aortic Regurgitation

Trilogy Heart Valve System – Transcatheter Aortic Valve Replacement Using the JenaValve Trilogy Heart Valve System for Clinically Significant Aortic Regurgitation in Patients with Left Ventricular Assist Devices (LVAD)

Trilogy Heart Valve System – Trilogy Heart Valve System for Management of Patients with Aortic Valve Disease: Patient Registry and Post-market Clinical Follow-up Study

Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

JensClip – Product Status

JensClip – Product Description

JensCloop – Product Status

JensCloop – Product Description

JensFlag – Product Status

JensFlag – Product Description

JensRelive – Product Status

JensRelive – Product Description

JensT-Clip – Product Status

JensT-Clip – Product Description

Ken-Valve – Product Status

Ken-Valve – Product Description

KenFlex – Product Status

KenFlex – Product Description

LuX-Valve – Product Status

LuX-Valve – Product Description

LuX-Valve Plus – Product Status

LuX-Valve Plus – Product Description

Jenscare Scientific Co Ltd – Ongoing Clinical Trials Overview

LuX-Valve – THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve Replacement with LuX-Valve Via Jugular Vein

LuX-Valve – The Travel Trial: Transcatheter Right Atrial-ventricular Valve replacement with LuX-valve

LuX-Valve Plus – TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT with LuX-Valve Plus System in Patients with Severe or Greater Tricuspid Regurgitation – SafetY and Clinical Performance

LuX-Valve Plus – Trial to Evaluate Transvenous Tricuspid Valve Replacement with LuX-Valve Plus System in Patients with Severe or Greater Tricuspid Regurgitation — Safety and Clinical Performance

JensClip – A Prospective, Multicenter, Single Group Target Value Study for Evaluating the Safety and Effectiveness of JensClip Transcatheter Valve Repair System in The Treatment of Functional Mitral Regurgitation

JensClip – A Prospective, Multicenter, Single-group Target Value Clinical Study to Evaluate the Safety and Efficacy of JensClip Transcatheter Valve Repair System in the Treatment of Moderate to Severe Degenerative Mitral Regurgitation

JensClip – Clinical Study Protocol of Jensclip Transcatheter Valve Clip and Delivery System for the Treatment of High-risk Patients with Moderate to Severe or Severe Mitral Regurgitation

Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Neoblazar Transcatheter Tricuspid Valve Repair System – Product Status

Neoblazar Transcatheter Tricuspid Valve Repair System – Product Description

Neonova Transcatheter Mitral Valve Repair System – Product Status

Neonova Transcatheter Mitral Valve Repair System – Product Description

Trudelta Transcatheter Mitral Valve Replacement System – Product Status

Trudelta Transcatheter Mitral Valve Replacement System – Product Description

Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Interventional Tricuspid Valve – Product Status

Interventional Tricuspid Valve – Product Description

Transcatheter Aortic Valve Replacement Device – Product Status

Transcatheter Aortic Valve Replacement Device – Product Description

Figures

Transcatheter Heart Valves – Pipeline Products by Stage of Development

Transcatheter Heart Valves – Pipeline Products by Segment

Transcatheter Heart Valves – Pipeline Products by Territory

Transcatheter Heart Valves – Pipeline Products by Regulatory Path

Transcatheter Heart Valves – Pipeline Products by Estimated Approval Date

Transcatheter Heart Valves – Ongoing Clinical Trials

Frequently asked questions

Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.